Supplementary Figure S5 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

DOI: 10.1158/1078-0432.25826727.v1 Publication Date: 2024-05-15T08:07:05Z